Edited by: Ken O'Halloran
Introduction
Intrapulmonary arteriovenous anastomoses (IPAVA) are present throughout the lung in many mammals, including humans, and range in size from 25 to 500 μm (Tobin, 1966; Lovering et al. 2007) . Although the pulmonary circulation facilitates gas exchange between the blood and alveoli, blood flow through IPAVA (Q IPAVA ) is believed to bypass sites of gas exchange, hindering pulmonary gas exchange efficiency (Stickland et al. 2004) . Normally,Q IPAVA is assessed using the technique of agitated saline contrast echocardiography in participants negative for intracardiac shunts and without pulmonary arteriovenous malformations . In these individuals,Q IPAVA increases in an exercise-intensity-dependent manner (Eldridge et al. 2004; Elliott et al. 2014b; Norris et al. 2014) and is exacerbated with acute normobaric hypoxia (Lovering et al. 2008a) . For example,Q IPAVA is non-detectable at rest in most healthy humans at both sea level (SL; Elliott et al. 2013 ) and high altitude (HA; Foster et al. 2014 ) but is present in >90% of participants during normoxic exercise and increases to 100% during hypoxic exercise (Lovering et al. 2008a; Elliott et al. 2011) . Given this interaction between exercise intensity and hypoxia, it seems logical thatQ IPAVA would be exacerbated when exercising at HA.
The primary purpose of the present study was to determine whetherQ IPAVA is increased during exercise during acclimatization to 5050 m. Interestingly, previous reports have shown thatQ IPAVA is minimized during exercise when hyperoxia [fraction of inspired O 2 (F I,O 2 ) = 1.0] is administered (Lovering et al. 2008b) . Therefore, the secondary purpose of this study was to identify whether hyperoxia regulatesQ IPAVA during exercise at HA in a similar manner to that at sea level. Finally, we conducted theoretical modelling on previously reported bubble diameter distributions at SL to estimate the impact of HA on saline contrast stability (Feinstein et al. 1984; Vuille et al. 1994) . We reasoned thatQ IPAVA would be greater during exercise at HA compared with similar workloads at SL and that hyperoxia would reduceQ IPAVA . We also speculated that the effect of HA on contrast stability would be negligible across the transit times expected during exercise from the point of injection to detection in the left ventricle.
Methods
All experimental procedures and protocols were submitted to and approved by the Clinical Research Ethics Board at the University of British Columbia and the Nepal Health Research Council, and conformed to the Canadian Government Tri-Council Policy Statement for research involving humans and the Declaration of Helsinki. All participants provided written informed consent before participation in this study. This study was part of a larger research expedition conducted in April-June 2012 Lewis et al. 2014; Smirl et al. 2014; Smith et al. 2014; Willie et al. 2014 Willie et al. , 2015 Stembridge et al. 2015) . As such, participants took part in a number of studies conducted in Kelowna, BC Canada (344 m) and during 3 weeks at the Ev-K2-CNR Pyramid Laboratory located near Mt Everest base camp at 5050 m. Participants involved in this study had a minimum of 48 h between studies to mitigate any concern of cross-contamination from pharmaceutical interventions.
Participants
Seventeen healthy participants volunteered for this study and were tested in Kelowna, BC, Canada near SL (elevation = 344 m). From this group of volunteers, seven (age = 33.1 ± 7.8 years; one female) were negative for a patent foramen ovale (PFO) based upon transthoracic agitated saline contrast echocardiography (Marriott et al. 2013) . As the purpose of this study was to determineQ IPAVA , participants were excluded if they had a PFO at rest or with a provocative manoeuvre (see 'Agitated saline contrast echocardiography'). These seven participants were studied at SL and HA. All participants studied met the inclusion criteria, including 18-49 years of age, non-smoking and free from any known history of neurological, respiratory and cardiovascular diseases. Participants were asked to refrain from caffeine, alcohol and vigorous exercise for at least 12 h before experimentation. Participants were not born at altitudes >1200 m and had not travelled to HA (>2500 m) within 6 months before SL testing. In addition, participants were excluded if they were hypertensive (>140/90 mmHg), had poor pulmonary function as determined by spirometry (i.e. forced expiratory volume in 1 s/forced vital capacity <0.75), or did not present with tricuspid regurgitation for the estimation of pulmonary artery systolic pressure L. M. Boulet and others (PASP). The results presented, unless otherwise specified, are based on seven participants.
Experimental protocol
Participants were studied on three separate occasions. First, participants attended the laboratory in Kelowna and were assessed for inclusion and exclusion criteria and completed an incremental exercise test to exhaustion (see specific methods below). Height and weight were measured, and spirometry (Vmax Spectra 20; Sensormedics, Yorba Linda, CA, USA) was conducted in accordance with the standards outlined by the American Thoracic Society and the European Respiratory Society (Miller et al. 2005) . Participants returned within 1 week to complete the SL submaximal exercise protocol. During this visit, participants were instrumented with an intravenous catheter at the antecubital fossa while resting supine on a hospital bed. Participants were then asked to lie in the supine position on a custom-built supine cycle ergometer. Following 5 min of rest, the participant was positioned in the left lateral decubitus position, and three consecutive blood pressure measurements were manually obtained from the right upper arm using a sphygmomanometer and stethoscope for auscultation of Korotkoff sounds. Also, at this time, peripheral arterial oxyhaemoglobin saturation (S pO 2 ; model 3100; WristOx, Nonin Medical Inc., Plymouth, MN, USA) was estimated by pulse oximetry of the right index finger. Next, baseline images were collected for stroke volume (in millilitres), cardiac output (Q ; in litres per minute) and PASP (in millimetres of mercury) by echocardiography. Heart rate (HR) was measured by standard two-lead ECG. Next, an apical four-chamber view of the heart was acquired, andQ IPAVA was determined by the technique of agitated saline contrast echocardiography. These experimental measurements were repeated during submaximal exercise stages (5 min each) equivalent to 25, 50 and 75% of SL peak oxygen consumption (V O 2 peak ). After the 75%V O 2 peak submaximal exercise stage at SL, participants were given a 10 min period of rest and then the stage was repeated while the participant was administered hyperoxic gas (F I,O 2 = 0.5). The F I,O 2 used to test hyperoxic reversibility ofQ IPAVA at SL (0.5) and HA (1.0) was selected to match a similar inspired P O 2 of ß350 mmHg.
Participants then travelled to Kathmandu, Nepal (1400 m), and after a week in Kathmandu, underwent an 8-10 day trek to the Ev-K2-CNR Pyramid Laboratory located at 5050 m in the Himalayan Mountains in Nepal under prophylactic acetazolamide administration (125 mg two times per day). Acetazolamide was discontinued 24 h before ascending from Pheriche (4300 m) to the laboratory (5050 m). Four to 7 days after arrival at 5050 m, participants conducted two submaximal exercise stages corresponding to 25 and 50% of SLV O 2 peak .
After the last stage of exercise, participants rested for 10 min before repeating the final stage in hyperoxic gas (F I,O 2 = 1.0).
Measurements
Maximal exercise testing. Using a custom-built supine cycle ergometer, participants underwent an incremental exercise test to exhaustion in normoxia to obtain relative peak power outputs at SL. The maximal exercise protocol was developed for individual participants to reach their maximal workload capacity in approximately 6-8 min.
The protocol began at 50 W, and workload increased by 50 W every minute until participants reached volitional exhaustion. During the maximal exercise protocol, expired gas was analysed for minute ventilation (V E ), O 2 uptake (V O 2 ), CO 2 production (V CO 2 ) and the respiratory exchange ratio (RER) (Vmax 29C; SensorMedics), and HR was determined by ECG (CardioSoft; GE Healthcare, Waukesha, WI, USA).
Pulmonary
haemodynamics. All echocardiography measurements were performed using the same commercially available ultrasound system (Vivid Q, 3.5 MHz transducer; GE Healthcare, Piscataway, NJ, USA) and by the same sonographer (M.S.) with several years of experience (Stembridge et al. 2015) . Initially, the diameter of the left ventricular outflow tract at the level of the aortic annulus was determined from the parasternal long-axis view. Measurements were taken at the end of systole, and the average of three cardiac cycles was taken as the diameter of the aorta. Then, the velocity-time integral of the left ventricular outflow tract was obtained from an apical five-chamber view by placing a pulsed-wave Doppler sample volume within the aortic valve. Stroke volume was calculated as the product of the velocity-time integral and aortic cross-sectional area, andQ was obtained by multiplication with HR. These methods have been previously described and validated against thermodilution and the direct Fick method (Christie et al. 1987) . Tricuspid regurgitation peak velocity was measured by continuous-wave Doppler ultrasound using colour flow imaging from the apical four-chamber view. The pulmonary artery pressure gradient was then estimated from the simplified Bernoulli equation, and PASP could be estimated by addition of right atrial pressure. Right atrial pressure was estimated from collapse of the inferior vena cava during inspiration as recommended by the American Society of Echocardiography (Rudski et al. 2010) . The collapsibility index was calculated as the percentage of difference between the maximal and minimal size of the inferior vena cava. This method has been validated against right atrial pressure obtained directly by right heart catheterization (Yildirimturk et al. 2011) . All pulmonary haemodynamic measurements were made on three cardiac cycles and averaged to provide a single value.
Agitated saline contrast echocardiography. The presence of a PFO was determined in resting conditions and during a release from Valsalva manoeuvre using the technique of agitated saline contrast echocardiography (Marriott et al. 2013) . Two 5 ml syringes were connected by two three-way stopcocks connected in line with each other and to a 22 gauge cannula placed in the antecubital vein. One syringe contained 4 ml of sterile saline and the other 0.5 ml of air. The two syringes were flushed back and forth rapidly and forcefully, creating microbubbles within the agitated saline solution before injection. Using an apical four-chamber view with harmonic imaging, microbubbles could be visualized travelling through the heart immediately after rapid injection of the agitated contrast. If a negative test was identified, a Valsalva manoeuvre was used to assess the patency of the foramen ovale further. A PFO was identified if contrast appeared in the left ventricle less than five cardiac cycles after the contrast filled the right atrium. After all contrast injections, a minimum of 20 cardiac cycles was recorded. In the event that a participant was identified as being PFO negative, they were then studied for restingQ IPAVA . An IPAVA was defined when contrast appeared in the left ventricle six or more cardiac cycles after the contrast appeared in the right atrium. This technique has been used to investigateQ IPAVA in participants at SL during rest and exercise breathing room air or during acute normobaric hypoxia (Stickland et al. 2004; Kennedy et al. 2012; Laurie et al. 2012; Tremblay et al. 2014; Elliott et al. 2014a Elliott et al. ,b, 2015 . In addition, this technique has been used to investigatė Q IPAVA at HA during rest . A previously published scoring system was used to determine the severity ofQ IPAVA based on the greatest density and spatial distribution of microbubbles in the left ventricle of a single cardiac cycle during the subsequent 20 cardiac cycles (Laurie et al. 2010 ). This 0-5 scoring system assigns a '0' for no microbubbles; '1' for one to three microbubbles; '2' for four to 12 microbubbles; '3' for >12 microbubbles bolus; '4' for >12 microbubbles heterogeneously distributed; and a '5' for >12 microbubbles homogeneously distributed. This scaling system has been validated for reproducibility against independent blinded observers ( Laurie et al. 2010) .
Model of contrast bubble dissolution. Equation (1), derived by Solano-Altamirano & Goldman (2014), provides the dissolution time for a gas bubble of a given radius in a fluid medium. The underlying model has three regions: a bubble; a diffusive region that surrounds the bubble; and a well-mixed region that surrounds the diffusive region. The bubble is spherical, and both the In the present study, P atm and PASP are measured, whereas the partial pressures of mixed venous nitrogen, oxygen and carbon dioxide are based on published reports at similar altitudes (George & Kinasewitz, 2005; Fenn et al. 1946; Wagner et al. 1986 ).
diffusive and the well-stirred regions are spherical shells. Diffusion is the only form of transport that is explicit in the model. Convection is considered indirectly and qualitatively, by using a three-region model, and the parameter λ. When λ = 1, the diffusion shell thickness is equal to 0, such that convection is the dominant transport mechanism; as λ approaches infinity, the model reduces to a two-region model, wherein diffusion is the only transport mechanism [see Solano-Altamirano & Goldman (2014)]:
Using this model, the time to bubble dissolution (t) can be estimated as a function of initial bubble radius (R 0 ) by setting the final bubble radius (R) to zero and solving the remaining constants as appropriate for the environmental conditions at SL and HA during rest and exercise. Table 1 provides a summary of key constants and parameters used to solve eqn (1). Diffusivity (D) was calculated using the Stokes-Einstein equation [eqn (2); Kholodenko & Douglas, 1995] Hoffman, 2011; Foster et al. 2014) .
In eqn (1). the external pressure (P e ) is assumed to be the sum of atmospheric pressure (P atm ) and PASP during each condition (PASP values measured in this study were used for the bubble dissolution model). The f ratio in eqn (1) is the ratio of the sum of all partial pressures of dissolved air in mixed venous blood (i.e. P vN 2 + P vO 2 + P vCO 2 + P vH 2 O ) to P e . The f ratio varies according to the difference in P atm , PASP and the partial pressure of constituent gases in mixed venous blood in different environmental and physical conditions (see Table 1 ). For example, at SL, P e is 780 mmHg (P atm = 760 mmHg and PASP = 20 mmHg) and at rest, the partial pressures of nitrogen, oxygen, carbon dioxide and water vapour in mixed venous blood are 573, 36, 39 and 47 mmHg, respectively (George & Kinasewitz, 2005; Wagner et al. 1986) , resulting in an f ratio of 0.891. Surface tension (γ) of the bubbles in blood is assumed to be 0.5 μatm at both SL and HA (Van Liew & Burkard, 1995) . The term λ is a constant used to account for the mixing and convection effects of the downstream compartment and has been set to a value of 2, similar to previous predictions involving gas emboli in circulating blood (Solano-Altamirano & Goldman, 2015) . Finally, d represents the Henry's solubility constant and is defined by RT/K H , where R is the gas constant, T is body temperature during rest and exercise, and K H is Henry's Law constant. Henry's law constant for air in water is first temperature corrected using the van't Hoff equation (Atkins & de Paula, 2006 ) and determined to be 1735 l atm mol −1 at rest and 1775 l atm mol −1 during exercise. Bubble dissolution time was calculated for bubble radii ranging in size from 0 to 20 μm by completing eqn (1) for resting conditions and exercise conditions expected at SL and HA. For each condition, the contrast lost over time was determined by generating decay curves based on a random normal distribution of bubble radii which had a mean and SD based on two individual published reports (8.0 ± 6.5 and 19.0 ± 7.5 μm; Feinstein et al. 1984; Vuille et al. 1994) . Using the dissolution time for each bubble within each distribution, contrast decay curves were generated to illustrate the time-dependent instability of saline contrast in all conditions.
Statistical analysis
Statistical comparisons and calculations were made using statistical software (R, http://cran.r-project.org). Two-way repeated-measures ANOVAs were used to test for differences inQ , PASP, S pO 2 and HR between rest and multiple exercise stages for both SL and HA. Bonferroni-corrected post hoc tests were used for pairwise comparisons. Friedman's test with Conover's post hoc test was used to test for differences in bubble scores between rest and exercise stages for both SL and HA. Correlation of shunt scores with both PASP andQ were conducted using Spearman's rank order correlation coefficient. For all tests, significance was assumed at P < 0.05.
Results
Participant characteristics and maximal exercise data are presented in Table 2 . Participants had normal pulmonary function and average exercise capacity. No participants included in this study had a PFO at rest or during a release from a Valsalva manoeuvre. Figure 1 illustrates the changes in PASP, HR andQ during supine cycle exercise at SL and at HA. Resting HR andQ were similar at SL and HA. During exercise, HR andQ increased with increasing exercise intensity in a similar manner between altitudes. The PASP was measured in all participants at SL, but at HA a high drive to breathe during exercise impacted image quality. As a result, PASP was measureable in only six of seven subjects at 25% SLV O 2 peak and three of seven at 50% SLV O 2 peak . Resting PASP was increased at HA by 6.4 ± 2.4 mmHg (P < 0.05). During exercise, PASP increased modestly with increasing exercise intensity, whereas the increase in PASP at HA was substantial, reaching values of 22.8 ± 2.4 and Exercise-induced intrapulmonary shunt at altitude 26.2 ± 3.3 mmHg above SL resting values (P < 0.05) during 25 and 50% SLV O 2 peak , respectively. At SL, hyperoxia had no appreciable effect on PASP, HR oṙ Q . At HA, hyperoxia trials were not conducted because there was little evidence ofQ IPAVA . The S pO 2 was not changed by exercise at SL (S pO 2 : rest = 97 ± 0.4%; 75% SLV O 2 peak = 96 ± 0.6%) but was reduced at HA and with HA exercise (S pO 2 : rest = 81 ± 2%; 50% SL V O 2 peak = 74 ± 2%).
Bubble score was zero in all participants at rest at SL. At rest at HA, with significantly elevated PASP and reduced S pO 2 , bubble score was measured to be zero in 
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two participants, one in three participants, and two in two participants, with a median score of one (Fig. 2) . As expected, bubble score increased with increasing exercise intensity at SL, with median values reaching a score of three at 75% SLV O 2 peak . Interestingly, hyperoxia reduced bubble score in only two participants. At HA, bubble scores were not increased with increasing exercise intensity. Owing to the lack of response with increasing exercise, hyperoxia trials were not conducted at HA. Figure 3 shows the relationship between bubble score and bothQ and PASP during exercise at SL and HA. At SL, a significant Spearman's rank order correlation coefficient (r s ) was found forQ (r s = 0.558, P < 0.001) and PASP (r s = 0.732, P < 0.001). Such relationships were absent at HA. The model of saline bubble dissolution time suggested that at SL, bubbles survive ß24% longer than at HA over a bubble radii range of 8-19 μm, representing mean radii measured in previous investigations ( Fig. 4A; Feinstein et al. 1984; Vuille et al. 1994) . Based on a mean bubble radius of 8 μm from Feinstein et al (1984) , the estimated time to dissolution was 4.2 s at SL and 3.2 s at HA in the resting state. Bubbles with a mean bubble radius of 19 μm reported by Vuille et al (1994) were found to have an estimated time to dissolution of 49.5 s at SL compared with 
. Theoretical model of microbubble stability
A, the time to bubble dissolution as a function of bubble radius in blood during rest and exercise at sea level and after 4-7 days of acclimatization to 5050 m. B, the estimated percentage of contrast conserved within a bolus of agitated saline contrast over time for bubbles in the pulmonary circulation during rest and exercise at sea level and after 4-7 days of acclimatization at 5050 m. Data are calculated based on the curves presented in A and a random normal bubble diameter distribution based on published reports of bubble diameter in agitated saline made at sea level (Feinstein et al. 1984; Vuille et al. 1994) . Outlined box represents the range of expected transit times from rest (ß9.3 s) to exercise (ß3.0 s; Hopkins et al. 1996) .
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.7 s at HA in a resting physiological state. In addition, the bubble stability is reduced in maximal exercise conditions at HA (Fig. 4A) . As a result, exercise at HA gives the shortest dissolution time because of the increase in pulmonary pressure and the decreased f ratio, which is ß3.1 or 38.3 s for mean radii proposed by Feinstein et al. (1984) and Vuille et al. (1994) , respectively. Figure 4B illustrates the decay of contrast over time, where it is observed that the time to dissolution is not only dependent upon the initial size of the bubble distribution but also on the altitude and physiological state (i.e. rest or exercise). However, the effect of the lost contrast is amplified with greater transit time (time from point of contrast creation to its visualization in the left ventricle). Hence, near maximal exercise, when transit time is least, the amount of contrast lost to dissolution is much less than in the resting state.
Discussion
In this study, we evaluatedQ IPAVA during submaximal exercise at SL and during acclimatization to HA (5050 m) using the technique of agitated saline contrast echocardiography. The three major findings of this study are as follows: (i) the lack of change inQ IPAVA from rest to 50% of SLV O 2 peak at HA; (ii) the loss of relationship between both PASP andQ withQ IPAVA with increasing exercise intensity at HA; and (iii) the time-to-dissolution model suggests that at near-maximal exercise the destabilizing effect of HA on saline bubbles is an unlikely explanation for the lack ofQ IPAVA during exercise at HA. These data suggest an overall lack ofQ IPAVA during exercise after 4-7 days of HA. This finding is in contrast to previous reports at SL that show an increase iṅ Q IPAVA during exercise in hypoxic conditions, suggesting that hypobaria or prolonged hypoxia may be an important regulator ofQ IPAVA . Although anatomical evidence confirms the existence of IPAVA in humans, it remains unclear whether they are actively or passively regulated. Graded exercise at SL typically results in an increase inQ IPAVA in nearly all participants (Eldridge et al. 2004; Stickland et al. 2004; Kennedy et al. 2012) , as does acute normobaric hypoxia (Lovering et al. 2008a; Laurie et al. 2010; Elliott et al. 2011; Bates et al. 2014; Norris et al. 2014) , suggesting that the increase inQ and PASP may contribute to IPAVA recruitment. This mechanical hypothesis suggests that IPAVAs could serve as a pressure-relief system to protect the pulmonary capillaries from high perfusion pressure associated with acute increases inQ . In this scenario, shear stress could serve as a stimulus that actively governṡ Q IPAVA , orQ IPAVA could be regulated passively through increases in pulmonary perfusion, causing recruitment of underperfused regions of the lungs that contain IPAVA. Studies that involve a pharmacological increase inQ show a concomitant increase inQ IPAVA (Bryan et al. 2012; Laurie et al. 2012; Elliott et al. 2014a) .
Our SL data are consistent with this hypothesis; we found a positive correlation betweenQ IPAVA and bothQ and PASP (Fig. 3) . The increases inQ IPAVA were attenuated by administering hyperoxia at SL (Fig. 2) , which is consistent with previous data, providing evidence for a possible second regulatory mechanism of a humoral nature that responds to circulating P O 2 (Elliott et al. 2014b; Duke et al. 2016; Tremblay et al. 2014) . Interestingly, the relationships betweenQ IPAVA and bothQ and PASP were absent after 4-7 days of acclimatization at 5050 m (Fig. 3) ; median bubble scores were one at rest, andQ IPAVA did not increase with exercise (Fig. 2 ) despite similarQ compared with SL and substantially augmented PASP (Fig. 2) . These data are in contrast to previous work and suggest an added level of complexity in IPAVA regulation, possibly involving pulmonary vascular remodelling in response to prolonged hypoxia (Stenmark et al. 2006) . Alternatively, a serious limitation regarding the agitated saline contrast methodology could be involved if the stability of this contrast agent was greatly reduced at 5050 m. Theoretical modelling data suggest that contrast instability is unlikely to account for the lack ofQ IPAVA during exercise, and a large portion of the discussion will be dedicated to the factors contributing to microbubble stability in the hypobaric environment.
In interpreting our data, it is tempting to attribute the lack ofQ IPAVA to a destabilizing effect associated with the low-density air within the microbubble in the HA environment. Evaluation ofQ IPAVA using a peripheral injection of agitated saline contrast is based on the assumption that as a bolus travels through the pulmonary circulation there are only two possible fates: (i) the bubbles travel through alveolar capillaries, where microbubbles dissolve and equilibrate with the alveolar gasses in the lung; or (ii) the bubbles travel through an IPAVA and are detectable in the left atrium ). This oversimplified model does not account for the limited stability of the microbubbles within blood vessels, which are susceptible to changes in blood gas concentrations, blood pressure, blood viscosity, bubble gas density and blood gas solubility (Epstein & Plesset, 1950) .
In the theoretical model of bubble stability presented here, the three major factors contributing to the difference of dissolution time between experimental conditions are diffusivity, ambient pressure and saturation ratio (f). Figure 4A illustrates that the decrease in diffusivity, primarily driven by a decrease in ambient pressure, causes an overall decrease in bubble stability. This instability at HA would be greater if not for the 2.7% increase in blood haematocrit (7% increase in blood viscosity) expected after 2-3 weeks of exposure to 5050 m of altitude . Comparison of rest and exercise states at SL and HA illustrates the importance of the saturation factor L. M. Boulet and others (f) and the change in external pressure (P e ; P atm + PASP) for bubble stability. The exponential increase in time to dissolution with bubble radius clearly suggests that the initial bubble size within a bolus of agitated saline contrast is the major governor of stability. This phenomenon is further illustrated in Fig. 4B , where it is apparent that there is a much slower rate of contrast decay in a bolus with large mean bubble sizes. Although the time-dependent decay of contrast and the contrast instability caused by hypobaria are important factors to consider when quantifyingQ IPAVA (Hackett et al. 2016) , it seems unlikely that during exercise, when transit time is short (ß2-5 s), the bubble instability would be of sufficient magnitude to observe no contrast in the left ventricle. For example, model data presented in Fig. 4B would suggest that, at a transit time of 3 s, the amount of contrast surviving its detection in the left ventricle would be 69.3% at SL and 64.0% at HA using the bubble diameter distributions reported by Feinstein et al. (1984) . This difference is negligible if using the bubble diameters reported by Vuille et al. (1994) . Given the fact that microbubbles are nearly as stable at HA compared with SL, it must be assumed that there is some physiological phenomenon that arrests the recruitment of IPAVA at HA during exercise.
Although this model has been shown to predict bubble characteristics accurately within the cardiovascular system (Solano-Altamirano & Goldman, 2014), it does not consider normal physiological changes in blood pressure or flow. Once infused, the bubble encounters a number of different pressure environments while travelling from the peripheral vein to its detection in the left ventricle, which could impact its stability. We assumed a constant pressure equal in magnitude to the pulmonary artery systolic pressure. As high pressures decrease bubble stability, our model is a conservative estimate of bubble stability. We acknowledge that the pulsatile nature of pulmonary arterial blood pressure could also threaten bubble stability, although previous work in an in vitro model determined that the oscillations in pressure were secondary to changes in peak pressure when determining stability (Padial et al. 1995) . Finally, it has been confirmed that increases in flow shorten the lifespan of a saline bubble (Yang et al. 1971) . Our model does not account for this flow effect, although it seems unlikely that the lack of contrast observed at HA can be attributed to flow given the similarQ between SL and HA (see Fig. 1 ). Based upon this theoretical evidence, the lack ofQ IPAVA observed in our study during exercise at HA appears to be a physiological phenomenon associated with exposure to hypobaric hypoxia or as a result of the HA acclimatization process.
Our results refute the expected outcome of the study and do not appear to be the result of altered saline contrast stability. Here, we offer some speculation into the physiological underpinnings for the lack ofQ IPAVA at HA during exercise. Previous reports (Lovering et al. 2015) have speculated that IPAVA have greater distribution in the underperfused apex of the lung and that IPAVA may offer pressure relief in response to increasing mean pulmonary artery pressure during hypoxic pulmonary vasoconstriction (HPV). In the case of severe hypoxia, such as hypobaric exercise, the multiple inert gas elimination technique has shown that ventilation-perfusion matching is impaired, possibly as a result of heterogeneity in the HPV response , which might discriminately divertQ away from IPAVA. However, the discrepancy between acute hypoxia-inducedQ IPAVA and the lack thereof at high altitude potentially implicates hypobaria, per se, as a regulator of IPAVA tone. Evidence that the pulmonary vasculature is responsive to hypobaria independent of O 2 status is available in the literature. For example, Levine et al. (1988) reported increased pulmonary vascular resistance in sheep decompressed to 6400 m while the F I,O 2 was increased to keep arterial P O 2 at normoxic values. Likewise, estimates of total pulmonary resistance by echocardiography in humans suggests an independent effect of hypobaria. In a group of eight subjects, total pulmonary resistance (PASP/Q ) was equal to 4.8 ± 1.7 mmHg l −1 min −1 in normobaria, but when decompressed to 5260 m while adding oxygen to maintain inspired P O 2 , the pulmonary resistance increased to 6.2 ± 1.8 mmHg l −1 min −1 (unpublished observations, A. Lovering). Although it is possible that hypobaria itself might directly affect pulmonary vascular tone or IPAVA patency, the specific mechanism is unknown. Finally, pulmonary vascular remodelling in response to prolonged HPV and increased pulmonary vascular pressure might impacṫ Q IPAVA measured after prolonged hypoxia. Pulmonary vascular remodelling occurs within 3 days of HA exposure in animals through the proliferation of smooth muscle cells in normally thin-walled small pulmonary arteries and the thickening of media and adventitia in larger pulmonary arteries (Stenmark et al. 2006) . It is not fully understood when pulmonary vascular remodelling begins in humans, but the inability to reverse HPV through the administration of hyperoxia, a diagnostic test for vascular remodelling, suggests that it can begin as early as 24 h postexposure (Kronenberg et al. 1971; Maggiorini et al. 2001) . Although our data clearly cannot implicate any of these hypotheses, they do offer future avenues for research.
We were able to study a limited number of participants (n = 7) at SL and HA, and this small sample size could be viewed as a limitation. However, 50% of SLV O 2 peak is nearly maximal at 5000 m and is therefore a sufficiently potent stimulus, which at SL would evoke a substantial increase inQ IPAVA . We are confident that our study was sufficiently powered (>80%) to detect a difference in bubble score at this exercise intensity, notwithstanding our sample size.
Conclusion
Despite significant elevations inQ and PASP during exercise at HA,Q IPAVA did not increase from resting values. Given that our theoretical model suggests that bubble stability is not sufficiently altered at HA compared with SL during the transit times of interest, our findings suggest that IPAVA recruitment at HA is not similar to recruitment during SL exercise or with acute normobaric hypoxia. Using our experimental design, we are not able to identify the specific physiological mechanism for the lack of exercise-inducedQ IPAVA at high altitude. Future studies might consider manipulating the duration of HA exposure or the level of hypobaria to help delineate whether hypobaria or pulmonary vascular remodelling is responsible for the lack of IPAVA recruitment with HA exposure.
